Who
Paul A. Jones
Chief People Officer
Company insider
Files Form 4 as: Chief People Officer, USANA Health Sciences.
In numbers
- Trades disclosed
- 167
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $8.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Apr 2013
- Last trade
- 8 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 8 Jun 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $103K5,561 at $18.50 | filing |
| 8 Jun 2026filed 8 Jun 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $103K5,561 at $18.50 | filing |
| 28 May 2026filed 29 May 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $129K6,813 at $18.95 | filing |
| 28 May 2026filed 29 May 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $129K6,813 at $18.95 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —4,596 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $29K1,349 at $21.52 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,596 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,596 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —4,596 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $29K1,349 at $21.52 | filing |
| 19 Feb 2026filed 23 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —25,622 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —25,622 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,514 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —2,514 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $19K872 at $21.34 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —2,514 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $19K872 at $21.34 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,514 at $0.00 | filing |
| 7 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,372 | filing |
| 7 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,372 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.